Biotech Stock News Bite – Candel Therapeutics, Inc. (Nasdaq: CADL) Big Gains on News of Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409

[ad_1] April 5, 2024 ( Newswire) ( Biotech Stock News Bites – Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, made the NASDAQ top ten percentage gainers list, currently trading at $8.92, up $2.52 or 39.43%. The stock had a morning … Read more

Biotech Stock News Bite – Avalo Therapeutics, Inc. (NASDAQ: AVTX) Makes NASDAQ Top Gainers List on News it acquired Phase 2-ready anti-IL-1β mAb

[ad_1] March 28, 2024 ( Newswire) ( Biotech Stock News Bites – Avalo Therapeutics, Inc. (Nasdaq: AVTX) blew other stocks away making the NASDAQ top percentage gainer in today’s session, currently trading at $ 22.58, up $17.83 for a gain of 382.12%. The stock had a morning high of $27.90. Avalo just announced it … Read more